NOURIANZ

This brand name is authorized in United States.

Active ingredients

The drug NOURIANZ contains one active pharmaceutical ingredient (API):

1
Istradefylline
UNII 2GZ0LIK7T4 - ISTRADEFYLLINE
 

Istradefylline is an adenosine receptor antagonist. The precise mechanism by which istradefylline exerts its therapeutic effect in Parkinson disease is unknown. In in vitro studies and in in vivo animal studies, istradefylline was demonstrated to be an adenosine A2A receptor antagonist.

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 NOURIANZ Film-coated tablet MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 42747-602, 42747-604

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈